Skip to main content
. 2022 May 3;9(5):652. doi: 10.3390/children9050652

Table 1.

Characteristics of UK school-aged children presenting with COVID-19 during periods of SARS-CoV-2 Alpha or Delta variant predominance.

Overall Symptomatic Children with Positive SARS-CoV-2 Test
Alpha Variant Period Delta Variant Period
Younger Children
(Aged 5–11 Years)
Older Children
(Aged 12–17 Years)
Overall Cohort
(Aged 5–17 Years)
Younger Children
(Aged 5–11 Years)
Older Children
(Aged 12–17 Years)
Overall Cohort
(Aged 5–17 Years)
Number 276 418 694 227 479 706
Males (n (%)) 144 (52.2) 213 (50.9) 357 (51.4) 102 (44.9) 255 (53.2) 357 (50.6)
Age, years (median (IQR)) 9 (7–10) 15 (13–16) 12 (9–15) 9 (8–11) 15 (13–16) 14 (13–16)
BMI (kg/m2) (median (IQR)) 16.44 (14.79–18.90) 19.53 (17.24–22.07) 18.16 (15.97–21.16) 16.68 (14.61–19.27) 18.97 (16.88–21.31) 18.21 (16.01–20.96)
Asthma (n (%)) 32 (11.6) 49 (11.7) 81 (11.6) 24 (10.6) 56 (11.7) 80 (11.3)
Heart disease (n (%)) 0 (0.0) 3 (0.9) 3 (0.4) 2 (0.7) 1 (0.2) 3 (0.4)
Diabetes (n (%)) 1 (0.4) 4 (1.0) 5 (0.8) 1 (0.4) 1 (0.2) 2 (0.3)
Renal disease (n (%)) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.2) 4 (0.1)
Number of children presenting to hospital * (n (%)) 6 (2.2) 8 (1.9) 14 (2.0) 8 (3.5) 8 (1.7) 16 (2.2)
Illness duration (median (IQR)) 4 (2–8) 6 (3–10) 5 (2–9.75) 4 (2–7.5) 6 (3–10) 5 (2–9)
Number of symptoms in the first week (median (IQR)) 3 (2–5) 5 (3–7) 4 (2–6) 4 (2–6) 6 (3–9) 5 (3–8)
Number of children with illness duration ≥ 28 days
(n (%))
2 (0.7) 10 (2.4) 14 (1.7) 3 (1.3) 12 (2.5) 15 (2.1)

BMI, Body Mass Index; IQR, Interquartile Range. * Presentation to hospital: presenting to the emergency department and/or admission to hospital.